Ayed O. Ayed
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Autoimmune and Inflammatory Disorders Research
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 6
-
- Chronic Myeloid Leukemia Treatments 3
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Lung‐Ji Chang (1 shared paper)Jan S. Moreb (2 shared papers)Ayalew Tefferi (1 shared paper)Elizabeth Cathcart-Rake (1 shared paper)Caitlin B. Conboy (1 shared paper)Inuk Zandvakili (1 shared paper)Thomas J. George (1 shared paper)John D. Reith (1 shared paper)
- Journals
- Blood (3 papers)American Journal of Hematology (2 papers)Targeted Oncology (1 paper)Leukemia Research (1 paper)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- United StatesItalyUkraine
In The Last Decade
Ayed O. Ayed
10 papers receiving 150 citations
Peers
Comparison fields: 5 of 37
- Hematology 83
- Genetics 50
- Pathology and Forensic Medicine 37
- Gastroenterology 11
- Immunology 39
Countries citing papers authored by Ayed O. Ayed
This map shows the geographic impact of Ayed O. Ayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayed O. Ayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayed O. Ayed more than expected).
Fields of papers citing papers by Ayed O. Ayed
This network shows the impact of papers produced by Ayed O. Ayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayed O. Ayed. The network helps show where Ayed O. Ayed may publish in the future.
Co-authors
The 25 scholars most cited alongside Ayed O. Ayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 35 | |
| 2 | 2010 | 33 | |
| 3 | 2015 | 26 | |
| 4 | 2015 | 25 | |
| 5 | 2018 | 16 | |
| 6 | 2017 | 8 | |
| 7 | 2017 | 5 | |
| 8 | 2016 | 2 | |
| 9 | 2014 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2025 | 0 |
About Ayed O. Ayed
Ayed O. Ayed is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Neurology and Infectious Diseases, having authored 11 papers that have together received 153 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Glioma Diagnosis and Treatment (2 papers), CAR-T cell therapy research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hematology (83 citations), Genetics (50 citations), Pathology and Forensic Medicine (37 citations), Gastroenterology (11 citations) and Immunology (39 citations). Ayed O. Ayed has collaborated with scholars based in United States, Italy and Ukraine. Frequent co-authors include Lung‐Ji Chang, Jan S. Moreb, Ayalew Tefferi, Elizabeth Cathcart-Rake, Caitlin B. Conboy, Inuk Zandvakili, Thomas J. George, John D. Reith, Xiaomin Lu and Abdalla Awidi. Their work appears in journals such as Blood, American Journal of Hematology, Targeted Oncology, Leukemia Research and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.